Ebina, Yasuhiko http://orcid.org/0000-0002-4119-7546
Mikami, Mikio
Nagase, Satoru
Tabata, Tsutomu
Kaneuchi, Masanori
Tashiro, Hironori
Mandai, Masaki
Enomoto, Takayuki
Kobayashi, Yoichi
Katabuchi, Hidetaka
Yaegashi, Nobuo
Udagawa, Yasuhiro
Aoki, Daisuke
Article History
Received: 18 September 2018
Accepted: 30 September 2018
First Online: 5 October 2018
Compliance with ethical standards
:
: (1) The Conflicts of Interest Committee of the JSGO discloses information on real or potential COIs of the members of the Drafting and Evaluation Committees for the Guidelines, as well as other relevant parties. The information can be confirmed via the Policy on Conflicts of Interest among Clinical Cancer Researchers, which can be viewed at ExternalRef removed (prepared by JSGO; in Japanese). The following corporations were disclosed by self‑declaration of the Drafting Committee members. ASKA Pharmaceutical Co., Ltd.; Otsuka Pharmaceutical Co., Ltd.; TSUMURA & Co.; Zeria Pharmaceutical Co., Ltd.; Chugai Pharmaceutical Co., Ltd.; Bayer Yakuhin Ltd.; Pfizer Japan Inc.; and Roche Diagnostics Co., Ltd. (2) Each recommendation was determined through consensus of all committee members and was not influenced by the interests of specific organizations, products, or technologies.